Lethal midline granuloma-nasal natural killer/T-cell lymphoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 2, 2006, Pages 202-206

  Mendenhall, William M ^a,b   Olivier, Kenneth R ^a   Lynch Jr , James W ^a   Mendenhall, Nancy Price ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chemotherapy; Lethal midline granuloma; Non Hodgkin lymphoma; Radiotherapy; T cell lymphoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; DISEASE EXACERBATION; DISSEMINATED CANCER; EYE TOXICITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDLINE GRANULOMA; MULTIMODALITY CANCER THERAPY; NATURAL KILLER T CELL; NONHODGKIN LYMPHOMA; NOSE CAVITY; PROGNOSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RARE DISEASE; REVIEW; SALVAGE THERAPY; SCHOOL CHILD; SEX RATIO; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT FAILURE; TREATMENT OUTCOME; DIFFERENTIAL DIAGNOSIS; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; SEX DIFFERENCE; SURVIVAL;

DIAGNOSIS, DIFFERENTIAL; GRANULOMA, LETHAL MIDLINE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; NEOPLASM STAGING; NOSE NEOPLASMS; PROGNOSIS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 33645789123     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000198738.61238.eb     Document Type: Review

References (30)

1. McBride P. Photographs of a case of rapid destruction of the nose and face, 1897. J Laryngol Otol. 1991;105:1120.
2. Borges A, Fink J, Villablanca P, et al. Midline destructive lesions of the sinonasal tract: simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol. 2000;21:331-336.
3. Lipford EH Jr, Margolick JB, Longo DL, et al. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674 -1681.
4. Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. Adv Anat Pathol. 2005;12:27-34.
5. Shikama N, Ikeda H, Nakamura S, et al. Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys. 2001;51:1228 -1233.
6. Kuo TT, Shih LY, Tsang NM. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004;12:375-387.
7. Kim K, Chie EK, Kim CW, et al. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol. 2005;35:1-5.
8. Rodriguez J, Romaguera JE, Manning J, et al. Nasal-type T/NK lymphomas: a clinicopathology study of 13 cases. Leuk Lymphoma. 2000;39:139 -144.
9. Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004;15:1467-1475.
10. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology (hematopathology section). Am J Surg Pathol. 1996;20:103-111.
11. Mishima K, Horiuchi K, Kojya S, et al. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer. 1994;73:3041-3046.
12. Lee PY, Freeman NJ, Khorsand J, et al. Angiocentric T-cell lymphoma presenting as lethal midline granuloma. Int J Dermatol. 1997;36:419-427.
13. Hartig G, Montone K, Wasik M, et al. Nasal T-cell lymphoma and the lethal midline granuloma syndrome. Otolaryngol Head Neck Surg. 1996;114:653- 656.
14. Aozasa K, Yang WI, Lee YB, et al. Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer. 1992;52:673- 674.
15. Smalley SR, Cupps RE, Anderson JA, et al. Polymorphic reticulosis limited to the upper aerodigestive tract: natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys. 1988;15:599 - 605.
16. Sakata K, Hareyama M, Ohuchi A, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol. 1997;36:307-311.
17. American Joint Committee on Cancer. Lymphoid Neoplasms. 6th ed. 2002:391- 405.
18. Sakata K, Hareyama M, Oouchi A, et al. Treatment of localized non-Hodgkin's lymphomas of the head and neck: focusing on cases of non-lethal midline granuloma. Radiat Oncol Investig. 1998;6:161-169.
19. Harabuchi Y, Kataura A, Imai K. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma. Ann Otol Rhinol Laryngol. 1996;105:634-642.
20. Chen HHW, Fong L, Su IJ, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol. 1996;38:1- 6.
21. Chott A, Rappersberger K, Schlossarek W, et al. Peripheral T cell lymphoma presenting primarily as lethal midline granuloma. Hum Pathol. 1988;19:1093-1101.
22. Grange C, Cabane J, Dubois A, et al. Centrofacial malignant granulomas: clinicopathologic study of 40 cases and review of the literature. Medicine. 1992;71:179 -196.
23. Maeda H, Aozasa K, Tsujimura T, et al. Malignant lymphomas and related conditions involving nasal cavity and paranasal sinuses: a clinicopathologic study of forty-two cases with emphasis on prognostic factors. Eur J Surg Oncol. 1988;14:9 -15.
24. Sobrevilla-Calvo P, Meneses A, Alfaro P, et al. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol. 1993;32:69 -72.
25. Senan S, Symonds RP, Brown IL. Nasal peripheral T-cell lymphomas: a 20-year review of cases treated in Scotland. Clin Oncol (R Coll Radiol). 1992;4:96 -100.
26. Kwong YL, Chan ACL, Liang R, et al. CD56* NK lymphomas: clinicopathological features and prognosis. Br J Haematol. 1997;97:821-829.
27. Feigenberg SJ, Mendenhall NP, Reith JD, et al. Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:620-626.
28. Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 1999;116:1313-1319.
29. Monroe AT, Bhandare N, Morris CG, et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005;61:856-864.
30. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005;61(4):1070 -1077.